Digital Biomarkers for Objectively and Remotely Monitoring Migraine

Overview

About this study

The purpose of this study is to measure changes in King-Devick Test (KDT) time during migraine phases and collect a detailed catalog of migraine episodes for a population of patients with migraine.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  1. 18 years of age or older
  2. Migraine with or without aura diagnosed according to ICHD3 diagnostic criteria
  3. 4-10 migraine attacks per month (average over the prior 3 months)
  4. Fewer than 15 headache days per month (average over the prior 3 months)
  5. Willing to provide KDT samples 3 times per day
  6. Willing to maintain a daily headache diary

 

Exclusion Criteria:

  1. Greater than 10 migraine attacks per month (average over the prior 3 months)
  2. 15 or greater headache days per month (average over the prior 3 months)
  3. Baseline ocular conditions
  4. Other neurologic diseases or history of intracranial surgery
  5. History of concussion within past 2 years

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Juliana VanderPluym, M.D.

Closed for enrollment

Contact information:

Juliana VanderPluym M.D.

(480)301-9443

VanderPluym.Juliana@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available